Letter from the Editor in ChiefDOI: 10.19102/icrm.2017.081202 MOUSSA MANSOUR, MD, FHRS, FACC
Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillatorDOI: 10.19102/icrm.2017.081203 KHUYEN DO, MD1, PHILIP CHANG, MD, FHRS1, TOMAS KONECNY, MD, PhD1, STEVEN K. CARLSON, MD1, HAN TUN, MPH, MBA, MBBS1, MARY HUNTSINGER, ACNP1 and RAHUL N. DOSHI, MD, FHRS1 1Keck USC Medical Center and LAC-USC Medical Center, Keck School of Medicine of USC, Los Angeles, California, USA
The Development of Innovative Handheld Devices to Augment Cardiopulmonary Resuscitation Therapy and External Cardioversion and DefibrillationDOI: 10.19102/icrm.2017.081201 MELANIE L. GERSHMAN1, BRANDON S. NEEDELMAN, BS1, SAM N. SCHWARZWALD, BS1 and TODD J. COHEN, MD1 1NYU Winthrop Hospital, Mineola, NY, USA
Left Atrial Appendage Closure to Prevent Strokes and Ligation to Prevent Atrial FibrillationDOI: 10.19102/icrm.2017.081204 CHRISTOPHER R. ELLIS, MD, FACC, FHRS1 1Vanderbilt Heart and Vascular Institute, Nashville, TN, USA
Innovations in Clinical Cardiac Electrophysiology: Challenges and Upcoming Solutions in 2018 and BeyondDOI: 10.19102/icrm.2017.081206 VAIBHAV R. VAIDYA, MBBS1, ALAN SUGURE, MBChB1 and SAMUEL J. ASIRVATHAM, MD1,2 1Division of Cardiac Electrophysiology, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
Intriguing Developments in Cardiac Mapping, Defibrillation, and PacingDOI: 10.19102/icrm.2017.081208 CLAUDIO TONDO, MD, PhD1 1Heart Rhythm Center at Monzino Cardiac Center, IRCCS, Department of Cardiac Sciences and Community Health, University of Milan, Milan, Italy
Review on Atrial FibrillationDOI: 10.19102/icrm.2017.081209 RAHUL N. DOSHI, MD, FHRS, FACC1 1University of Southern California Keck School of Medicine, Los Angeles, CA, USA
Electrical Therapy of Heart FailureDOI: 10.19102/icrm.2017.081207 IMRAN NIAZI, MD1 1Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke’s Medical Centers, University of Wisconsin School of Medicine and Public Health, Milwaukee, WI, USA
Implantable Cardioverter-defibrillator Therapy in the Patient with a Left Ventricular Assist Device: Still a Black BoxDOI: 10.19102/icrm.2017.081205 TRAVIS RICHARDSON, MD1 and CHRISTOPHER R. ELLIS, MD, FACC, FHRS1 1Vanderbilt Heart and Vascular Institute, Nashville, TN, USA
Letter from the Editor in ChiefDOI: 10.19102/icrm.2017.081105 MOUSSA MANSOUR, MD, FHRS, FACC
|
|